Mammalian Reverse Genetics without Crossing Reveals Nr3a as a Short-Sleeper Gene

Cell Reports

Volumn 14, Issue 3, 2016, Pages 662-677

  Sunagawa, Genshiro A ^a   Sumiyama, Kenta ^a   Ukai Tadenuma, Maki ^a   Perrin, Dimitri ^a,e   Fujishima, Hiroshi ^a   Ukai, Hideki ^a   Nishimura, Osamu ^d   Shi, Shoi ^b   Ohno, Rei ichiro ^b   Narumi, Ryohei ^a   Shimizu, Yoshihiro ^a   Tone, Daisuke ^b   Ode, Koji L ^b   Kuraku, Shigehiro ^d   Ueda, Hiroki R ^a,b,c  

^a RIKEN Center for Biosystems Dynamics Research   (Japan)

^b UNIVERSITY OF TOKYO   (Japan)

^c JAPAN SCIENCE AND TECHNOLOGY AGENCY   (Japan)

^d RIKEN   (Japan)

^e QUEENSLAND UNIVERSITY OF TECHNOLOGY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

N METHYL DEXTRO ASPARTIC ACID RECEPTOR; MONOPHENOL MONOOXYGENASE; NR3A NMDA RECEPTOR;

ADULT; ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; CRISPR CAS SYSTEM; FEMALE; GENE; GENE EXPRESSION; GENE SEQUENCE; GENE TARGETING; MALE; MEASUREMENT ACCURACY; MOUSE; NONHUMAN; NR3A GENE; PHENOTYPE; PRIORITY JOURNAL; REVERSE GENETICS; SLEEP WAKING CYCLE; ANIMAL; C57BL MOUSE; DEFICIENCY; ELECTROENCEPHALOGRAPHY; ELECTROMYOGRAPHY; GENETICS; GENOTYPE; KNOCKOUT MOUSE; METABOLISM; PHYSIOLOGY; SLEEP; WAKEFULNESS;

ANIMALS; CRISPR-CAS SYSTEMS; ELECTROENCEPHALOGRAPHY; ELECTROMYOGRAPHY; FEMALE; GENOTYPE; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MONOPHENOL MONOOXYGENASE; PHENOTYPE; RECEPTORS, N-METHYL-D-ASPARTATE; REVERSE GENETICS; SLEEP; WAKEFULNESS;

EID: 84953296346     PISSN: None     EISSN: 22111247     Source Type: Journal    
DOI: 10.1016/j.celrep.2015.12.052     Document Type: Article

References (47)

1. Autry A.E., Adachi M., Nosyreva E., Na E.S., Los M.F., Cheng P.F., Kavalali E.T., Monteggia L.M. NMDA receptor blockade at rest triggers rapid behavioural antidepressant responses. Nature 2011, 475:91-95.
2. Azzalini A., Torelli N. Clustering via nonparametric density estimation. Stat. Comput. 2007, 17:71-80.
3. Bae K., Jin X., Maywood E.S., Hastings M.H., Reppert S.M., Weaver D.R. Differential functions of mPer1, mPer2, and mPer3 in the SCN circadian clock. Neuron 2001, 30:525-536.
4. Belforte J.E., Zsiros V., Sklar E.R., Jiang Z., Yu G., Li Y., Quinlan E.M., Nakazawa K. Postnatal NMDA receptor ablation in corticolimbic interneurons confers schizophrenia-like phenotypes. Nat. Neurosci. 2010, 13:76-83.
5. Carbery I.D., Ji D., Harrington A., Brown V., Weinstein E.J., Liaw L., Cui X. Targeted genome modification in mice using zinc-finger nucleases. Genetics 2010, 186:451-459.
6. Chemelli R.M., Willie J.T., Sinton C.M., Elmquist J.K., Scammell T., Lee C., Richardson J.A., Williams S.C., Xiong Y., Kisanuki Y., et al. Narcolepsy in orexin knockout mice: molecular genetics of sleep regulation. Cell 1999, 98:437-451.
7. Cirelli C., Bushey D., Hill S., Huber R., Kreber R., Ganetzky B., Tononi G. Reduced sleep in Drosophila Shaker mutants. Nature 2005, 434:1087-1092.
8. De Valck E., Cluydts R. Sleepiness as a state-trait phenomenon, comprising both a sleep drive and a wake drive. Med. Hypotheses 2003, 60:509-512.
9. Edgar D.M., Seidel W.F. Modafinil induces wakefulness without intensifying motor activity or subsequent rebound hypersomnolence in the rat. J. Pharmacol. Exp. Ther. 1997, 283:757-769.
10. Flores A.E., Flores J.E., Deshpande H., Picazo J.A., Xie X.S., Franken P., Heller H.C., Grahn D.A., O'Hara B.F. Pattern recognition of sleep in rodents using piezoelectric signals generated by gross body movements. IEEE Trans. Biomed. Eng. 2007, 54:225-233.
11. Forrest D., Yuzaki M., Soares H.D., Ng L., Luk D.C., Sheng M., Stewart C.L., Morgan J.I., Connor J.A., Curran T. Targeted disruption of NMDA receptor 1 gene abolishes NMDA response and results in neonatal death. Neuron 1994, 13:325-338.
12. Fu Y., Sander J.D., Reyon D., Cascio V.M., Joung J.K. Improving CRISPR-Cas nuclease specificity using truncated guide RNAs. Nat. Biotechnol. 2014, 32:279-284.
13. Fujii W., Kawasaki K., Sugiura K., Naito K. Efficient generation of large-scale genome-modified mice using gRNA and CAS9 endonuclease. Nucleic Acids Res. 2013, 41:e187.
14. Glaab T., Taube C., Braun A., Mitzner W. Invasive and noninvasive methods for studying pulmonary function in mice. Respir. Res. 2007, 8:63.
15. Gordon C.J., Ali J.S. Measurement of ventilatory frequency in unrestrained rodents using microwave radiation. Respir. Physiol. 1984, 56:73-79.
16. Henson M.A., Roberts A.C., Pérez-Otaño I., Philpot B.D. Influence of the NR3A subunit on NMDA receptor functions. Prog. Neurobiol. 2010, 91:23-37.
17. Hernandez A.B., Kirkness J.P., Smith P.L., Schneider H., Polotsky M., Richardson R.A., Hernandez W.C., Schwartz A.R. Novel whole body plethysmography system for the continuous characterization of sleep and breathing in a mouse. J. Appl. Physiol. (1985) 2012, 112:671-680.
18. Horvath P., Barrangou R. CRISPR/Cas, the immune system of bacteria and archaea. Science 2010, 327:167-170.
19. Hsu P.D., Lander E.S., Zhang F. Development and applications of CRISPR-Cas9 for genome engineering. Cell 2014, 157:1262-1278.
20. Kitano H. Computational systems biology. Nature 2002, 420:206-210.
21. Kitano H. Systems biology: a brief overview. Science 2002, 295:1662-1664.
22. Koek W., Woods J.H., Winger G.D. MK-801, a proposed noncompetitive antagonist of excitatory amino acid neurotransmission, produces phencyclidine-like behavioral effects in pigeons, rats and rhesus monkeys. J. Pharmacol. Exp. Ther. 1988, 245:969-974.
23. Laposky A., Easton A., Dugovic C., Walisser J., Bradfield C., Turek F. Deletion of the mammalian circadian clock gene BMAL1/Mop3 alters baseline sleep architecture and the response to sleep deprivation. Sleep 2005, 28:395-409.
24. Li Y., Erzurumlu R.S., Chen C., Jhaveri S., Tonegawa S. Whisker-related neuronal patterns fail to develop in the trigeminal brainstem nuclei of NMDAR1 knockout mice. Cell 1994, 76:427-437.
25. Li N., Lee B., Liu R.-J., Banasr M., Dwyer J.M., Iwata M., Li X.-Y., Aghajanian G., Duman R.S. mTOR-dependent synapse formation underlies the rapid antidepressant effects of NMDA antagonists. Science 2010, 329:959-964.
26. Ma M., Ye A.Y., Zheng W., Kong L. A guide RNA sequence design platform for the CRISPR/Cas9 system for model organism genomes. BioMed Res. Int. 2013, 2013:270805.
27. McShane B.B., Galante R.J., Biber M., Jensen S.T., Wyner A.J., Pack A.I. Assessing REM sleep in mice using video data. Sleep 2012, 35:433-442.
28. Moghaddam B., Javitt D. From revolution to evolution: the glutamate hypothesis of schizophrenia and its implication for treatment. Neuropsychopharmacology 2012, 37:4-15.
29. Mohamad O., Song M., Wei L., Yu S.P. Regulatory roles of the NMDA receptor GluN3A subunit in locomotion, pain perception and cognitive functions in adult mice. J. Physiol. 2013, 591:149-168.
30. Mohn A.R., Gainetdinov R.R., Caron M.G., Koller B.H. Mice with reduced NMDA receptor expression display behaviors related to schizophrenia. Cell 1999, 98:427-436.
31. Nagy A. Manipulating the Mouse Embryo: A Laboratory Manual 2003, Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY. Third Edition.
32. Radulovacki M., Sreckovic G., Zak R., Zahrebelski G. Diazepam and midazolam increase light slow-wave sleep (SWS1) and decrease wakefulness in rats. Brain Res. 1984, 303:194-196.
33. Ran F.A., Hsu P.D., Wright J., Agarwala V., Scott D.A., Zhang F. Genome engineering using the CRISPR-Cas9 system. Nat. Protoc. 2013, 8:2281-2308.
34. Sasaki Y.F., Rothe T., Premkumar L.S., Das S., Cui J., Talantova M.V., Wong H.K., Gong X., Chan S.F., Zhang D., et al. Characterization and comparison of the NR3A subunit of the NMDA receptor in recombinant systems and primary cortical neurons. J. Neurophysiol. 2002, 87:2052-2063.
35. Shi M., Yue Z., Kuryatov A., Lindstrom J.M., Sehgal A. Identification of Redeye, a new sleep-regulating protein whose expression is modulated by sleep amount. eLife 2014, 3:e01473.
36. Shimba S., Ogawa T., Hitosugi S., Ichihashi Y., Nakadaira Y., Kobayashi M., Tezuka M., Kosuge Y., Ishige K., Ito Y., et al. Deficient of a clock gene, brain and muscle Arnt-like protein-1 (BMAL1), induces dyslipidemia and ectopic fat formation. PLoS ONE 2011, 6:e25231.
37. Shiromani P.J., Xu M., Winston E.M., Shiromani S.N., Gerashchenko D., Weaver D.R. Sleep rhythmicity and homeostasis in mice with targeted disruption of mPeriod genes. Am. J. Physiol. Regul. Integr. Comp. Physiol. 2004, 287:R47-R57.
38. Snyder E.M., Nong Y., Almeida C.G., Paul S., Moran T., Choi E.Y., Nairn A.C., Salter M.W., Lombroso P.J., Gouras G.K., Greengard P. Regulation of NMDA receptor trafficking by amyloid-beta. Nat. Neurosci. 2005, 8:1051-1058.
39. Sumiyama K., Kawakami K., Yagita K. A simple and highly efficient transgenesis method in mice with the Tol2 transposon system and cytoplasmic microinjection. Genomics 2010, 95:306-311.
40. Sunagawa G.A., Sei H., Shimba S., Urade Y., Ueda H.R. FASTER: an unsupervised fully automated sleep staging method for mice. Genes Cells 2013, 18:502-518.
41. Sung Y.H., Baek I.J., Kim D.H., Jeon J., Lee J., Lee K., Jeong D., Kim J.S., Lee H.W. Knockout mice created by TALEN-mediated gene targeting. Nat. Biotechnol. 2013, 31:23-24.
42. Tong G., Takahashi H., Tu S., Shin Y., Talantova M., Zago W., Xia P., Nie Z., Goetz T., Zhang D., et al. Modulation of NMDA receptor properties and synaptic transmission by the NR3A subunit in mouse hippocampal and cerebrocortical neurons. J. Neurophysiol. 2008, 99:122-132.
43. van der Horst G.T., Muijtjens M., Kobayashi K., Takano R., Kanno S., Takao M., de Wit J., Verkerk A., Eker A.P., van Leenen D., et al. Mammalian Cry1 and Cry2 are essential for maintenance of circadian rhythms. Nature 1999, 398:627-630.
44. Wang H., Yang H., Shivalila C.S., Dawlaty M.M., Cheng A.W., Zhang F., Jaenisch R. One-step generation of mice carrying mutations in multiple genes by CRISPR/Cas-mediated genome engineering. Cell 2013, 153:910-918.
45. Wiedenheft B., Sternberg S.H., Doudna J.A. RNA-guided genetic silencing systems in bacteria and archaea. Nature 2012, 482:331-338.
46. Wisor J.P., O'Hara B.F., Terao A., Selby C.P., Kilduff T.S., Sancar A., Edgar D.M., Franken P. A role for cryptochromes in sleep regulation. BMC Neurosci. 2002, 3:20.
47. Zhou J., Wang J., Shen B., Chen L., Su Y., Yang J., Zhang W., Tian X., Huang X. Dual sgRNAs facilitate CRISPR/Cas9-mediated mouse genome targeting. FEBS J. 2014, 281:1717-1725.